Category: News


New Blood Cancer Discoveries Grant Program Launched

The Leukemia & Lymphoma Society (LLS), The Mark Foundation for Cancer Research (MFCR), and The Paul G. Allen Frontiers Group (PAFG) are proud to announce the Blood Cancer Discoveries Grant Program (BCDG), a new grant program designed to encourage basic research, technological innovation, and informatics pipeline development that can lead to an understanding of blood … Continued

New Center at University of Pennsylvania Launched

$12 Million Awarded to Study Radiation Therapy and Immune Signaling NEW YORK – The Mark Foundation for Cancer Research announced today that it has awarded a grant of $12 million to establish The Mark Foundation Center for Immunotherapy, Immune Signaling, and Radiation at the University of Pennsylvania. The Center will bring together cross-departmental teams of … Continued

Three New Innovation Projects Funded

NEW YORK, NY — The Mark Foundation for Cancer Research announced today that it has given ASPIRE Awards for three projects. The total amount funded is $2.3 million for five years. The projects funded include the following: A Broad Institute and Dana-Farber Cancer Institute study to broadly characterize genetic variations and increase the number of … Continued

Strategic Collaboration with Evotec in Immuno-oncology Announced

Evotec AG and The Mark Foundation for Cancer Research today announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics in oncology. The collaboration, for an initial period of two years, is based on Evotec’s new proprietary drug discovery platform TargetAlloMod, which is focused on disrupting cell signalling via a … Continued

The Mark Foundation Hosts its Inaugural Scientific Symposium

Fourteen New Cancer Innovation Projects Funded

$3.4 million in ASPIRE Awards Announced to Support Cancer Research NEW YORK, NY — The Mark Foundation for Cancer Research has selected fourteen outstanding scientific research projects for ASPIRE Awards. Designed to answer key proof-of-concept questions in a short timeframe, the ASPIRE (Accelerating Scientific Platforms and Innovative Research) program funds high risk, high reward approaches … Continued

Partnership with Cancer Research UK to Fund a Grand Challenge Team Announced

The Mark Foundation for Cancer Research has partnered with Cancer Research UK to give a Grand Challenge award to a team led by Stephen Elledge, PhD at Brigham and Women’s Hospital, Harvard Medical School.  Dr. Elledge’s team is one of three global research teams led by U.S.-based investigators to collectively receive ~$75 million as part … Continued

Announcing the Inaugural Cohort of the Emerging Leader Awards

The Mark Foundation Funds Eight High-Risk, High-Reward Projects NEW YORK, NY — The Mark Foundation for Cancer Research has awarded eight grants to promising early career scientists for projects aimed at addressing substantially unmet needs in cancer risk prediction, prevention, detection, and treatment. The Mark Foundation’s Emerging Leader Awards accelerate innovation by supporting potentially transformative … Continued

Therapeutic Innovation Awards Announced

In partnership with the Chordoma Foundation, The Mark Foundation for Cancer Research is pleased to announce the recipients of the 2018 Therapeutic Innovation Awards. Jointly launched earlier this year, this award program is designed to support innovative research projects aimed at discovering the first drugs that target brachyury, a protein believed to be the Achilles’ … Continued

New ASPIRE Award to Enable Adoptive Cell Therapy

The Mark Foundation for Cancer Research has announced Michelle Krogsgaard, PhD of New York University School of Medicine as its latest ASPIRE Award recipient. An Associate Professor in the Department of Pathology, Dr. Krogsgaard and her collaborators propose the development of a humanized transgenic mouse model by building artificial human chromosomes that will provide a robust … Continued